Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
Species specificity of a novel factor which augments the expression of MHC class I antigens on tumor cell lines
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 June 1997

Species specificity of a novel factor which augments the expression of MHC class I antigens on tumor cell lines

  • Niti Puri1,
  • Aparna Raval &
  • Rajiv K Saxena 

Experimental & Molecular Medicine volume 29, pages 129–132 (1997)Cite this article

  • 760 Accesses

  • 1 Citations

  • Metrics details

Abstract

A novel factor which augments the expression of major histocompatibility complex I (MHC augmenting factor or MHC-AF) antigens on tumor cell lines, has been isolated from the culture supernatants of human peripheral blood mononuclear cells activated by concanavalin-A. A mouse equivalent of this factor has also been isolated from the culture supernatants of mouse spleen cells activated by mitogens or in a mixed lymphocyte reaction. Mouse MHC-AF enhances the expression of class I MHC antigens on murine tumor cell lines (EL-4 and BW5147) but not on human tumor cell lines (K562 and HR-7). Human MHC-AF on the other hand enhances the MHC I expression on both human as well as murine cell lines. Interferon γ (IFN-γ), a cytokine also known to enhance the expression of MHC I antigens, acts in a highly species specific manner with mouse IFN-γ augmenting the MHC I on murine tumor cell lines and human IFN-γ augmenting the MHC I on human tumor cell lines only. These results indicate important differences in the cross species biological activities of MHC-AF and IFN-γ, and provide additional evidence for MHC-AF being distinct from IFN-γ.

Similar content being viewed by others

MHC II immunogenicity shapes the neoepitope landscape in human tumors

Article 09 January 2023

Modulation of MHC expression by interferon-gamma and its influence on PBMC-mediated cytotoxicity in canine mast cell tumour cells

Article Open access 01 August 2024

Developing an erythrocyte‒MHC-I conjugate for cancer treatment

Article Open access 01 October 2024

Article PDF

Author information

Authors and Affiliations

  1. School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India

    Niti Puri

Authors
  1. Niti Puri
    View author publications

    Search author on:PubMed Google Scholar

  2. Aparna Raval
    View author publications

    Search author on:PubMed Google Scholar

  3. Rajiv K Saxena
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Puri, N., Raval, A. & Saxena, R. Species specificity of a novel factor which augments the expression of MHC class I antigens on tumor cell lines. Exp Mol Med 29, 129–132 (1997). https://doi.org/10.1038/emm.1997.19

Download citation

  • Published: 01 June 1997

  • Issue date: 01 June 1997

  • DOI: https://doi.org/10.1038/emm.1997.19

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • major histocompatibility complex
  • lymphokines
  • lymphocytes
  • interferon γ
Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited